These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 26182354)

  • 1. Hepcidin: regulation of the master iron regulator.
    Rishi G; Wallace DF; Subramaniam VN
    Biosci Rep; 2015 Mar; 35(3):. PubMed ID: 26182354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulators of hepcidin expression.
    Roth MP; Meynard D; Coppin H
    Vitam Horm; 2019; 110():101-129. PubMed ID: 30798807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on iron metabolism and molecular perspective of common genetic and acquired disorder, hemochromatosis.
    Yun S; Vincelette ND
    Crit Rev Oncol Hematol; 2015 Jul; 95(1):12-25. PubMed ID: 25737209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
    Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
    Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic iron homeostasis and erythropoiesis.
    Papanikolaou G; Pantopoulos K
    IUBMB Life; 2017 Jun; 69(6):399-413. PubMed ID: 28387022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin and the BMP-SMAD pathway: An unexpected liaison.
    Silvestri L; Nai A; Dulja A; Pagani A
    Vitam Horm; 2019; 110():71-99. PubMed ID: 30798817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepcidin-ferroportin axis in health and disease.
    Ginzburg YZ
    Vitam Horm; 2019; 110():17-45. PubMed ID: 30798811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.
    Reichert CO; da Cunha J; Levy D; Maselli LMF; Bydlowski SP; Spada C
    Acta Haematol; 2017; 137(4):220-236. PubMed ID: 28514781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endofin, a novel BMP-SMAD regulator of the iron-regulatory hormone, hepcidin.
    Goh JB; Wallace DF; Hong W; Subramaniam VN
    Sci Rep; 2015 Sep; 5():13986. PubMed ID: 26358513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin-mediated hypoferremic response to acute inflammation requires a threshold of Bmp6/Hjv/Smad signaling.
    Fillebeen C; Wilkinson N; Charlebois E; Katsarou A; Wagner J; Pantopoulos K
    Blood; 2018 Oct; 132(17):1829-1841. PubMed ID: 30213871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of hepcidin and iron-overload disease.
    Lee PL; Beutler E
    Annu Rev Pathol; 2009; 4():489-515. PubMed ID: 19400694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin regulates intrarenal iron handling at the distal nephron.
    Moulouel B; Houamel D; Delaby C; Tchernitchko D; Vaulont S; Letteron P; Thibaudeau O; Puy H; Gouya L; Beaumont C; Karim Z
    Kidney Int; 2013 Oct; 84(4):756-66. PubMed ID: 23615502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance.
    Babitt JL; Huang FW; Xia Y; Sidis Y; Andrews NC; Lin HY
    J Clin Invest; 2007 Jul; 117(7):1933-9. PubMed ID: 17607365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological focus on the erythropoietin-hepcidin-ferroportin axis.
    D'Anna MC; Roque ME
    Can J Physiol Pharmacol; 2013 May; 91(5):338-45. PubMed ID: 23656253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis of iron overload disorders and iron-linked anemias.
    Kaplan J; Ward DM; De Domenico I
    Int J Hematol; 2011 Jan; 93(1):14-20. PubMed ID: 21210258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.
    Ganz T; Nemeth E
    Semin Nephrol; 2016 Mar; 36(2):87-93. PubMed ID: 27236128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenine alleviates iron overload by cAMP/PKA mediated hepatic hepcidin in mice.
    Zhang Y; Wang X; Wu Q; Wang H; Zhao L; Wang X; Mu M; Xie E; He X; Shao D; Shang Y; Lai Y; Ginzburg Y; Min J; Wang F
    J Cell Physiol; 2018 Sep; 233(9):7268-7278. PubMed ID: 29600572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation of hepcidin and its effects on systemic and cellular iron metabolism.
    Fleming MD
    Hematology Am Soc Hematol Educ Program; 2008; ():151-8. PubMed ID: 19074074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of hepcidin to treat iron deregulation: potential clinical applications.
    Blanchette NL; Manz DH; Torti FM; Torti SV
    Expert Rev Hematol; 2016; 9(2):169-86. PubMed ID: 26669208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular basis of hepcidin-resistant hereditary hemochromatosis.
    Fernandes A; Preza GC; Phung Y; De Domenico I; Kaplan J; Ganz T; Nemeth E
    Blood; 2009 Jul; 114(2):437-43. PubMed ID: 19383972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.